Transplant Infectious Disease Fellowship— Accreditation & Program Guide

What Is Transplant Infectious Disease Fellowship?

Transplant Infectious Disease (Transplant ID) is advanced subspecialty training pursued after completion of a standard ACGME-accredited Infectious Disease fellowship. It focuses on the prevention, diagnosis, and management of infections in solid-organ transplant (SOT) and hematopoietic stem cell transplant (HSCT) recipients — two populations whose immunosuppression creates infectious risk profiles that general ID training addresses incompletely.

The clinical problems are distinct enough to justify dedicated training: net state of immunosuppression varies by organ, induction regimen, and rejection history; prophylaxis protocols are organ- and center-specific; opportunistic pathogens behave differently in this host; and dosing decisions must account for immunosuppressant drug interactions and altered pharmacokinetics. Transplant ID physicians serve as consultants, program builders, and often the institutional authority on prophylaxis guideline development and donor-derived infection workup.

This is not a rebranded general ID fellowship. It is a post-fellowship training year for physicians who have already completed ACGME-accredited ID training and want to work at the intersection of transplant medicine and infectious disease in an academic or large transplant-center environment.

Accreditation Status — Plainly Stated

Transplant ID fellowship is not ACGME-accredited. This is the single most important structural fact about this pathway and it carries real downstream consequences that anyone considering it should understand before applying.

What "not ACGME-accredited" means in practice:

• No Match. There is no NRMP or equivalent match process. Every position is filled through direct, uncoordinated negotiation between the applicant and the program.
• No standardized curriculum requirements. ACGME program requirements specify what must be taught, in what volume, and with what supervision. None of that applies here. Two programs calling themselves "Transplant ID fellowships" may train you in substantially different ways.
• No duty-hour oversight. ACGME duty-hour rules do not apply. Some programs mirror them voluntarily; others do not.
• No standard grievance or oversight mechanism. If a program underdelivers on its stated curriculum, there is no accreditation body to complain to. Your recourse is institutional, not regulatory.
• Completion does not confer a separately ABMS-recognized subspecialty certificate. As of the current publication date, there is no ABMS board certification in Transplant ID. You will hold ID board certification; your Transplant ID training is documented by a completion letter from the program, not a separate board certificate. This may change — advocacy for formal accreditation exists within professional societies — but it has not changed yet.
• Funding is not federally mandated. GME funding mechanisms that support ACGME positions do not automatically apply. Positions are funded at institutional discretion (see the salary section below).

None of this makes the training less valuable clinically or professionally. It does mean you must do more due diligence before accepting a position than you would for an accredited fellowship, because you cannot assume any baseline structure is in place.

Who Oversees These Programs?

Oversight is voluntary and distributed across several organizations, none of which has binding accreditation authority.

The Infectious Diseases Society of America (IDSA) maintains a database of advanced ID fellowships and has published guidelines describing what Transplant ID programs should include. IDSA does not accredit programs; it provides a voluntary framework and a listing mechanism. Programs can list themselves without meeting any verified standard.

The American Society of Transplantation (AST) has an Infectious Diseases Community of Practice that produces clinical guidance and engages with Transplant ID training. AST does not accredit fellowships but is increasingly active in workforce and training discussions.

Individual institutions bear the actual responsibility for what gets taught. The quality of a Transplant ID fellowship is heavily dependent on the volume and mix of the transplant program, the clinical faculty, protected time for education, and the culture of the ID division. This is why site-specific due diligence matters more here than in accredited fellowship searches.

There is active discussion within IDSA and AST about formalizing accreditation, but no accreditation structure exists as of this writing. Monitor IDSA and AST communications directly for any changes.

Typical Program Length and Structure

Most Transplant ID fellowships are one year in length. A minority of programs offer a two-year track with a dedicated research year appended; this is more common at programs affiliated with large NIH-funded transplant research infrastructure.

A representative one-year clinical structure at a high-volume center might include:

• Inpatient consult service covering SOT and HSCT recipients, often as the primary ID consult fellow with direct attending supervision
• Dedicated time on the HSCT service or bone marrow transplant unit
• Outpatient transplant ID clinic, covering pre-transplant infectious risk assessment, post-transplant follow-up, and management of chronic viral infections (CMV, BKV, EBV, HBV, HCV)
• Rotations through clinical microbiology, often with direct interaction with the transplant-dedicated lab protocols
• Participation in multidisciplinary transplant committee meetings and infection control rounds

Weekly structure varies considerably by program. Some run as a traditional consult fellow with heavy inpatient volume; others are structured more like a clinical-research hybrid with protected academic half-days. Ask programs directly for a sample weekly schedule and a list of recent fellows' scholarly output — both are reasonable requests and programs that refuse them are telling you something.

Prerequisites: What You Must Have Before Applying

The prerequisites are narrow and largely non-negotiable:

• Completion of an ACGME-accredited Infectious Disease fellowship, or concurrent enrollment in your final year of ID fellowship at the time of application. Most programs want you to have completed ID before you start; some will consider applicants in their final ID year for positions beginning after ID graduation.
• Board eligibility in Infectious Disease at the time you begin the Transplant ID position. Some programs will want you to have sat for or passed ID boards; expectations vary and you should confirm this directly.
• Clinical exposure to immunocompromised hosts. This is typically satisfied by standard ID fellowship training, but applicants who have additional transplant service or oncology ID rotations during ID fellowship are more competitive.
• A credible research record is expected at most programs, even if not formally required. At minimum, prior abstract presentations and ideally peer-reviewed publications are competitive differentiators in a small, uncoordinated market where programs are selecting directly.

There is no USMLE score cutoff enforced by any central body, because there is no central body. Individual programs set their own thresholds informally. If your exam history is complicated, frame it through your overall trajectory and clinical record — see the application section below.

How Applications Work (No Match, Direct Outreach)

Because there is no match, no centralized application portal, and no coordinated timeline, the application process for Transplant ID is entirely relationship- and outreach-driven. This is both a structural feature and a source of real inequity — applicants without networks must be more deliberate about building them.

Timeline. Begin identifying programs and making contact approximately 12 to 18 months before your intended start date. Most programs fill positions in an informal rolling process. Waiting until 6 months out is late for competitive programs.

How to find programs. Use the IDSA advanced fellowship database as your primary starting list. Cross-reference with the AST Infectious Diseases Community of Practice membership and transplant center directories. Word-of-mouth through your ID fellowship program director and ID attendings with transplant relationships is often the most reliable sourcing mechanism. There is no FREIDA equivalent for this subspecialty.

Initial contact. Email the program director or division chief directly. A cold email is entirely appropriate and expected. The email should be concise, specific, and professional — identify who you are, where you are in ID training, why you are interested in their program specifically (not generic interest in Transplant ID), and ask whether they anticipate having a position for your target year. Attach your CV.

Letter of intent. Most programs will ask for a letter of intent as part of a dossier. An effective letter of intent for Transplant ID should:

• Identify your current training position and expected completion date
• Describe specific clinical experience with immunocompromised hosts that is relevant — not a recitation of ID fellowship duties, but the specific cases, rotations, or research that pointed you toward transplant
• Name a clinical or research question you want to pursue during fellowship, with enough specificity to demonstrate that you have read the program's published work
• State your career intent plainly: academic transplant center, large community transplant program, or research-focused career

CV highlights that matter in this context: transplant-related publications or presentations, letters from ID attendings with transplant experience, any prior research with immunocompromised populations, and institutional exposure to high-volume SOT or HSCT programs. If your training institution has a small transplant program, name it accurately and compensate by describing how you sought additional exposure.

For applicants without established networks: Attending the IDSA annual meeting or the AST Transplant Infectious Diseases Symposium and introducing yourself to program directors in person is a legitimate and effective strategy. Present research if you can — abstract presentations are sufficient at this stage. These are small professional communities and face recognition matters in a process with no anonymizing match.

What You Will Learn: Core Competencies

The clinical competencies developed in Transplant ID training are specific and transferable to any large transplant center. Well-structured programs should train you in all of the following:

• Pre-transplant infectious risk assessment: Screening donors and recipients for latent infections (TB, endemic fungi, herpesvirus serostatus, hepatitis B and C, HIV), and determining transplant eligibility from an infectious standpoint
• Prophylaxis protocol design and management: CMV prophylaxis versus preemptive strategies; PCP prophylaxis; antifungal prophylaxis selection based on transplant type, organ, and net immunosuppression; duration decisions as immunosuppression tapers
• Viral management in the immunocompromised host: CMV disease versus viremia, BK nephropathy, EBV-associated PTLD surveillance, HBV reactivation, HCV management post-transplant, adenovirus and other opportunistic viral infections in HSCT
• Invasive fungal infections: Aspergillus and other mold management in lung and HSCT recipients, Candida in abdominal transplant, emerging resistance patterns, therapeutic drug monitoring for azoles and echinocandins
• Donor-derived infections: Unexpected donor-derived pathogen transmission, Public Health Service increased-risk donor evaluation, reporting obligations, and coordination with OPOs
• PK/PD dosing in immunocompromised hosts: Calcineurin inhibitor interactions with azole antifungals, renal dosing in transplant with fluctuating function, therapeutic drug monitoring in altered volume of distribution states
• Multidisciplinary communication: Functioning effectively in transplant team meetings, communicating infectious risk to surgeons and hepatologists making listing decisions, and translating complex infectious data for patients and families
• Infection control in transplant units: Outbreak investigation, isolation protocol rationale, construction-related fungal risk, and water safety in immunocompromised host units

Programs vary in how much HSCT versus SOT exposure they provide. If your career interest is weighted toward one over the other, ask directly about case volume and attending coverage in your target area.

Research and Scholarly Activity Expectations

Virtually every program that considers itself serious about Transplant ID training expects trainees to produce at least one abstract submission and to make meaningful progress on a manuscript during the fellowship year. Whether that manuscript is published during the fellowship or shortly after is a reasonable distinction — a year is short — but the expectation of scholarly productivity is consistent.

Clinical-track programs emphasize volume and breadth of clinical exposure, with research expectations calibrated to one project and one submission. These are appropriate for trainees heading to large clinical transplant centers without a primary research mission.

Research-track programs — typically two years — are designed for trainees who intend to pursue NIH funding, build a research program, or join a faculty with protected research time. These programs often have extramural funding in transplant immunology, viral pathogenesis, or clinical epidemiology of post-transplant infection. If academic research productivity is your goal, a research-track program at a funded lab is worth the additional year.

Before accepting any position, ask to see the publication record of the last three to five fellows. A program that cannot produce this list is telling you something about its mentorship infrastructure. Ask specifically: who is the research mentor, what is their current funding status, and what projects are available for incoming fellows. Vague answers to specific questions warrant follow-up or caution.

Salary, Funding, and Benefits Reality Check

Transplant ID fellows are typically compensated on an institutional postdoctoral or PGY-equivalent scale. Because there is no federal GME funding mandate for unaccredited positions, actual compensation and how it is sourced varies by institution.

For current figures, see the PGY Zero salary data page — we do not embed specific dollar ranges in this editorial content because they shift annually. In general terms: compensation tends to track PGY-7 or PGY-8 institutional scales at academic medical centers, though some programs fund fellows through divisional research accounts at rates that may differ from clinical trainee scales. Confirm the funding source and stability when you receive an offer.

Benefits variability is real and consequential. Health insurance, malpractice coverage, leave policies, and travel and conference funding are not standardized. Ask for the benefits summary in writing before accepting. Specific questions worth asking:

• Is malpractice coverage occurrence-based or claims-made, and is a tail policy provided?
• Is conference travel funded, and what is the annual cap?
• Is moonlighting permitted, and under what conditions?
• What is the parental leave policy for your institution's postdoctoral or fellow category?

Because this is an unaccredited position, you have more negotiating latitude than in an ACGME-matched fellowship — but only if you ask. Offers are not always final as stated.

How to Find Programs: A Practical Directory Approach

There is no FREIDA equivalent for Transplant ID. Program discovery requires triangulating across several sources:

• IDSA Fellowship Database: The IDSA maintains a listing of advanced ID fellowships, including Transplant ID positions, on its website. This is the closest thing to a central directory and should be your first stop. Programs self-report and listings may lag reality — a program may exist that is not listed, and a listed program may not be currently recruiting.
• AST Infectious Diseases Community of Practice: AST membership directories and the ID CoP leadership roster can identify active Transplant ID faculty at major centers, many of whom run or are affiliated with fellowship programs.
• Your ID program director: This is an underused resource. Established ID fellowship directors have collegial relationships with transplant ID faculty nationwide. A personal introduction from your program director carries more weight than a cold email in a market this small.
• IDSA and AST annual meetings: Transplant ID sessions and networking events at these meetings are where the community concentrates. Attending with intent — identifying target faculty in advance, attending their sessions, introducing yourself — is an efficient use of a single trip.
• PubMed: Identify authors of recent Transplant ID publications at centers with active transplant programs. Corresponding authors at academic centers are often the program directors or senior fellows in these programs. Reading the work before reaching out gives you substantive material for a first contact email.

Build a target list of five to eight programs, rank them by your actual priorities (volume, HSCT vs. SOT balance, research infrastructure, geography, funding), and begin outreach in a coordinated wave rather than serially. Because there is no match, an offer may come with a short decision window. Having already evaluated your other targets helps you make a real decision under time pressure.

Career Outcomes and Job Market

Transplant ID is a narrow subspecialty with a correspondingly small but coherent job market. Career outcomes are shaped by the type of training received and the scope of the transplant center environment.

Academic medical centers with large transplant programs are the primary employer. These positions typically involve a mix of clinical consultation, outpatient transplant ID clinic, and faculty-level research or program development responsibilities. They require fellowship training and, typically, ID board certification; Transplant ID fellowship completion is expected and sometimes formally required.

Large community transplant centers are an expanding niche. As transplant volume grows outside academic quaternary centers, demand for dedicated Transplant ID expertise is following. These positions tend to be more clinically intensive with less protected research time.

Pharmaceutical, biotechnology, and contract research: Transplant ID physicians have an identifiable market value in drug development for antifungals, antivirals, and immunosuppression-related infectious complications. Fellowship training and clinical credibility in immunocompromised host management are relevant qualifications for medical affairs, clinical development, and advisory roles.

Workforce trajectory: The intersection of growing transplant volume, increasing complexity of immunosuppressive regimens, and the emergence of novel pathogens in this population creates structural demand for this subspecialty. This is a field where well-trained clinicians are genuinely sought, particularly at programs that have previously operated without dedicated Transplant ID coverage. That said, geographic concentration matters — positions cluster at centers with active transplant surgery programs, which are not uniformly distributed.

Fellowship completion does not guarantee placement; the match between your training profile, research record, and target employer expectations determines outcomes. Physicians who treat Transplant ID as a clinical-only credential without building any scholarly record may find academic positions harder to access than those who treat the fellowship year as a research launch.

Comparing Transplant ID to Other Advanced ID Fellowships

Several adjacent advanced ID fellowships address immunocompromised host infections from different angles. Knowing the differences helps confirm whether Transplant ID is the right pathway.

HIV/Immunocompromised Host Fellowship: Some programs offer advanced training focused on HIV medicine and broader immunocompromised host management. These fellowships may overlap with Transplant ID in HSCT coverage but typically do not include the SOT-specific competencies — prophylaxis protocols, donor-derived infection evaluation, transplant committee participation, calcineurin inhibitor interactions — that define Transplant ID training. If your career interest is HIV medicine or hematologic malignancy ID without a transplant center focus, this track is more appropriate.

Antimicrobial Stewardship Fellowship: Stewardship fellowships train ID physicians to lead institutional antibiotic optimization programs. While Transplant ID physicians often contribute to stewardship programs and stewardship training complements Transplant ID, they are distinct career paths. Stewardship fellowship is appropriate if your primary goal is program leadership in antibiotic use rather than transplant-specific clinical consultation.

Clinical Microbiology Fellowship (ACGME-accredited): This is the only adjacent advanced ID subspecialty that is ACGME-accredited and leads to a separate ABMS board certificate (through the American Board of Pathology or the American Board of Medical Microbiology pathway). If laboratory direction, diagnostic test development, or microbiology department leadership is your goal, Clinical Microbiology fellowship is the structured, board-certifiable path. It is not a substitute for Transplant ID clinical training if clinical consultation is your intent.

The cleanest decision rule: if you want to be the person called when a kidney transplant recipient develops disseminated Aspergillus at week eight post-transplant, or when a lung transplant program needs to build a new CMV surveillance protocol, Transplant ID is the training that prepares you for that role. If your interest is more diffuse across immunocompromised populations, stewardship systems, or laboratory medicine, one of the adjacent tracks may be a better fit.

Next Steps: Building Your Candidacy Starting Today

The informal, network-dependent structure of Transplant ID applications means that early, deliberate action compounds. The following steps are executable immediately regardless of where you are in ID fellowship training.

1. Identify five to eight target programs this week. Use the IDSA fellowship database, PubMed author searches, and the AST ID CoP directory. For each program, note: the program director's name, current funding (check their NIH Reporter profile), recent fellows' publication output (search PubMed), and transplant program volume at their institution (SRTR data for SOT programs is publicly available). Produce a written list with these fields completed before you do anything else.

2. Draft your letter of intent now, even if you are 18 months from applying. Writing a draft early forces you to identify what is missing in your story. If you cannot yet name a specific clinical question or name the program's published work, the draft will show you that gap and give you time to fill it.

3. Seek a clinical rotation at a transplant center if your current training does not include one. Email an ID attending at a transplant center — ideally someone who has published in Transplant ID — and ask about a rotation or observer experience. A one- to two-month elective in your ID fellowship at a high-volume transplant program changes your letter of intent from generic to specific, and occasionally leads directly to a fellowship offer.

4. Identify a research project with transplant relevance in your current program. Even a modest retrospective study or case series involving transplant recipients gives you something concrete to discuss in interviews and a potential abstract for submission. Talk to your ID fellowship program director about available datasets or QI projects in the transplant service.

5. Set a 12-month outreach calendar. If your target start date is July of a given year, your first emails to program directors should go out no later than the prior July, with follow-up in September and October. Mark these dates now. Programs that fill early will not wait for you to feel ready.

6. Tell your ID fellowship program director your plan explicitly. They may have direct relationships with Transplant ID program directors at your target centers. A personal introduction converts a cold email into a warm one. This is the highest-leverage single action available to you if your program director has any transplant ID network.